Does BUROSUMAB Cause Injection site swelling? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Injection site swelling have been filed in association with BUROSUMAB (CRYSVITA). This represents 1.3% of all adverse event reports for BUROSUMAB.
9
Reports of Injection site swelling with BUROSUMAB
1.3%
of all BUROSUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site swelling From BUROSUMAB?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Injection site swelling Listed in the Official Label?
Yes, Injection site swelling is listed as a known adverse reaction in the official FDA drug label for BUROSUMAB.
What Other Side Effects Does BUROSUMAB Cause?
Product dose omission issue (124)
Pain (69)
Inappropriate schedule of product administration (64)
Arthralgia (59)
Therapy interrupted (57)
Blood phosphorus decreased (53)
Pain in extremity (50)
Restless legs syndrome (49)
Back pain (35)
Fatigue (34)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which BUROSUMAB Alternatives Have Lower Injection site swelling Risk?
BUROSUMAB vs BUROSUMAB-TWZA
BUROSUMAB vs BUSPIRONE
BUROSUMAB vs BUSULFAN
BUROSUMAB vs BUSULFEX
BUROSUMAB vs BUTALBITAL